Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Petras Dzeja

Petras Dzeja

Mayo Clinic, USA USA

Petra Fromme

Petra Fromme

Arizona State University USA

Henry M Sobell

Henry M Sobell

University of Rochester USA

Boris Zaslavsky

Boris Zaslavsky

Cleveland Diagnostics USA

John F Cipollo

John F Cipollo

Center for Biologics Evaluation and Research-USFDA USA

Timothy A Cross

Timothy A Cross

Florida State University & National High Magnetic Field Lab USA

Xuequn Chen

Xuequn Chen

School of Medicine, Wayne State University USA

Alan J. Tackett

Alan J. Tackett

University of Arkansas for Medical Sciences , USA USA

Metabolomics Congress 2018

Sessions/Tracks

ConferenceSeries Ltd 11th International Conference and Exhibition on Metabolomics & Systems Biology during May 17-19, 2018  Tokyo, Japan . The attending delegates include Editorial Board Members of related OMICS Group Journals. This is a fabulous open door for the representatives from Universities and Institutes to communicate with the world class Scientists.

Metabolomics Congress 2018 Conference will be an investigation of New research Innovation of Metabolomics and spread the most recent advancements and patterns in Metabolomics displaying, Proteomics, Systems Biology, Genomics, Precision Medicine, Lipidomics, LC-MS and GC-MS Techniques, Bioinformatics, Plant Metabolomics, Clinical metabolomics, tumor and digestion system, computational science, metabolomics disorder, Nutritional Metabolomics, Therapeutic Metabolomics and more. Metabolomics is of enthusiasm to doctors in light of the fact that it might prompt enhancements in the conclusion and medications of human illnesses. Metabolomics as an order makes utilization of systematic procedures, for example, spectroscopy, chromatography, and multivariable investigation. Metabolomics permits researchers to gauge physiological impacts and to screen for unfavorable responses to tranquilizes.

Theme: Metabolomics: From Fundamentals to Clinical Applications
 

Track 1 : Cancer Therapeutic Approaches 

Cancer biomarkers have expanded immensely giving extraordinary chances to enhancing so as to enhance the administration of disease patients the proficiency of discovery and viability of treatment. Late innovative headway has empowered the examination of numerous potential biomarkers and recharged enthusiasm for growing new biomarkers. Biomarkers of disease could incorporate a wide scope of biochemical elements, for example, nucleic acids, proteins, sugars, lipids, and little metabolites, cytogenetic and cytokinetic parameters and additionally entire tumor cells found in the body liquid. A far reaching comprehension of the pertinence of each biomarker will be vital for diagnosing the illness dependably, as well as help in the decision of different remedial options as of now accessible that is prone to advantage the patients. A biological molecule found in blood, other body liquids, or tissues that is an indication of a typical or strange procedure, or of a condition or sickness. A biomarker might be utilized to perceive how well the body reacts to a treatment for a sickness or condition. Also called molecular marker and signature molecule.

Relevant Metabolomics Conferences Biochemistry Conferences

Track 2 : Metabolic Syndrome

Metabolomic profiling has been used to recognize novel biomarkers and instruments of cardiovascular malady hazard. Support and Metabolism Center and Center for Human Genetics at Duke University where the examination is proceeding with National Institutes of Health grants .Metabolomics can give certain inclinations in admiration to other "omics" progressions in diabetes research. CEDAM (Center for Endocrinology, Diabetes and Metabolism) investigation is centered around a seat to-bedside approach, taking examination through from essential science exposure to clinical application. Metabolomic approach gives novel encounters into the robotic investigations of antitumor prescriptions from a point specific from customary pharmaceutical examinations. Metabolic profiling is the multiparallel relative evaluation of a blend of mixes or compound classes utilizing chromatography and all inclusive discovery advancements (GC-MS, LCMS). Metabolic profiling can supplement routine frameworks and other "omics" propels in inquiring about preclinical prescription change issues. 

Relevant Metabolomics Conferences Biochemistry Conferences

Track 3 : Metabolomics in Precision Medicine

Precision medicine is an approach to manage finding and making solutions and antibodies that passes on unrivaled results for patients, by fusing clinical and sub-nuclear information to fathom the natural reason of infection. Pharmacometabolomics illuminates and compliments pharmacogenomics and together they give building pieces to Quantitative and Systems Pharmacology. Precision medicine is a rising methodology for illness treatment and avoidance that considers singular variability in qualities, environment, and way of life for every individual. While a few advances in exactness prescription have been made, the practice is not as of now being used for most diseases. Accuracy offers cutting edge answers for augment your achievement in translational examination. The appearance of monstrous parallel sequencing is dependable of an outlook change in biomarker disclosure and clinical trial plan while in transit to what is currently called "biomarker-driven disease solution" or "accuracy pharmaceutical." 

Relevant Metabolomics Conferences Biochemistry Conferences

Track 4 : Frontiers of Metabolomics Research

Metabolomic studies can incite enhanced cognizance of disease instruments and to new indicative markers furthermore redesigned perception of medication for solution or xenobiotic impact and expanded capacity to anticipate singular variety in medication reaction phenotypes. Howard University Center for Computational Biology and Bioinformatics (CCBB) is to empower and propel the use of computational approaches to manage the examination of biomedical and disease frames. New programming and progressively complex NMR metabolitespectral databases are impelling the fascinating limits of NMR spectroscopy to perceive and assess little particles in answer for examinations of metabolite biomarkers and metabolic flux. MS appreciates a solid point of interest in affectability contrasted and NMR and, through utilization of various blends of chromatographic techniques and mass/charge partition innovations, gives the capacity to gauge a more extensive cluster of little particle metabolites.

Relevant Metabolomics Conferences Biochemistry Conferences

Track 5 : Therapeutic Metabolomics

The role of metabolism in invulnerability has been underexplored along these lines, yet then researchers have made basic duties in depicting relationship of safe methods and metabolic pathways. Frameworks immunology means to think about the invulnerable framework in the more coordinated viewpoint on how elements and players take part at various framework levels to the safe function. Computational immunology is a field of science that incorporates high-throughput genomic and bioinformatics ways to deal with immunology. 

Relevant Metabolomics Conferences Biochemistry Conferences

Track 6 : Transcriptomics & Metabolic pathways

Transcriptomics is worried with deciding how the transcriptome, and subsequently example of quality expression, changes regarding different components, for example, kind of tissue, phase of advancement, hormones, medications, or ailment. It supplements and covers with proteomics. Metabolic pathway is a progression of concoction responses happening inside of a cell. In a pathway, the beginning compound (metabolite) is changed by an arrangement of synthetic responses. These responses are catalyzed by catalysts, where the result of one compound goes about as the substrate for the following. These chemicals frequently require dietary minerals, vitamins, and different cofactors to work.

Relevant Metabolomics Conferences Biochemistry Conferences

Track 7 : Metabolic Modelling

Metabolomic profiling is frequently performed with either Nuclear magnetic resonance (NMR) or MS. Individual analytes inside of the specimen are isolated by their attractive reverberation move or mass-to-charge proportion, separately, bringing about an otherworldly profile of partition. At the point when working with natural liquids, NMR regularly does not require substance control of an example, though MS for the most part requires derivatization of metabolites to create ionic species that are all the more promptly isolated by the mass-to-charge proportion. Metabolism is an essential cell procedure, and its glitch can be a noteworthy donor to numerous human sicknesses. Metabolites can serve as a metabolic ailment biomarker. Recognition of such biomarkers assumes a huge part in the investigation of biochemical response and flagging systems.

Relevant Metabolomics Conferences Biochemistry Conferences

Track 8 : Clinical Metabolomics & Lipidomics

Metabolomics and lipidomics, extreme mechanical assemblies in systems science, hope to screen little metabolites present in natural illustrations. Contrasts in the species or measures of metabolites can be used to depict phenotypes and common responses to inconveniences. Translational Biomarker Discovery Core fuse recognizing, supporting and making pre-clinical biomarkers for working up the region of illness, observing reduction status, choosing the practicality of specific therapeutic traditions, and controlling the decision of specific accommodating interventions. Biomarkers of ailment could consolidate a wide extent of biochemical components, for instance, nucleic acids, proteins, sugars, lipids, and little metabolites, cytogenetic and cytokinetic parameters and moreover whole tumor cells found in the body fluid. An extensive perception of the relevance of each biomarker will be basic for diagnosing the ailment constantly, and also help in the choice of various healing choices starting now open that is inclined to advantage the patients.

Relevant Metabolomics Conferences Biochemistry Conferences

Track 9 : Plant & Environmental Metabolomics

Metabolomics is the examination of endogenous and exogenous low atomic mass metabolites inside of a cell, tissue, or biofluid of a life form in light of an outer stressor. The sub-control of environmental metabolomics is the utilization of metabolomic strategies to investigate the connections of life forms with their surroundings. Drug metabolism system is the procedure by which the body separates and changes over pharmaceutical into dynamic concoction substances. Toxicology is a branch of Medical Science that arrangements with the impacts of synthetic compound utilized as a part of the conclusion, treatment, or counteractive action of ailment or other unusual condition on the body. Plant Metabolomics is to contemplate the plant framework at the sub-atomic level giving non-one-sided characterization of the total metabolite pool (metabolome) of plants under particular conditions. Using Metabolomics, a better understanding of the correlation between genes and the biochemical composition of a plant tissue in response to its environment (phenotype) can be obtained, and this information can be further used to assess gene function (genotype). Four joint U.S. also, Japanese research groups have been recompensed subsidizing totaling about $12 million (about Yen 960 million) to grow new naturally well disposed strategies to expand the creation of renewable biofuel and lessen pesticide use.

Relevant Metabolomics Conferences Biochemistry Conferences

Track 10 : Food & Nutritional Metabolomics

Unlike other ‘omics’ technologies (genomics, proteomics…etc), metabolomics gives organic understanding that mirrors an individual's one of a kind hereditary unique mark, as well as way of life, eating routine and environment. Utilizing metabolomics, scientists can quantitatively dissect non-hereditary variables that are included in postgenomic and posttranscriptional change. Nutritional metabolomics is quickly developing to utilize little atom substance profiling to bolster incorporation of eating regimen and sustenance in complex biosystems research. Nutrigenomics is a branch of nutritional genomics and is the study of the effects of foods and food constituents on gene expression. Foodomics has been recently defined as a new discipline that studies food and nutrition domains through the application of advanced omics technologies in which MS techniques are considered indispensable. Applications of Foodomics include the genomic, transcriptomic, proteomic, and/or metabolomic study of foods for compound profiling, authenticity, and/or biomarker-detection related to food quality or safety; the development of new transgenic foods, food contaminants, and whole toxicity studies; new investigations on food bioactivity, food effects on human health. The University of Michigan Nutrition Obesity Research Center (UM NORC) started in 2010, supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The UM NORC is one of 12 U.S. focuses intended to move and backing translational, multi-disciplinary exploration in heftiness and sustenance, over the continuum of fundamental science to applications in people (solution) and populations (public health).

Relevant Metabolomics Conferences Biochemistry Conferences

Track 11: Metabolomic devices

Metabolomics, alternately metabonomics, a rising field of biochemical exploration, is a reciprocal procedure to genomics, transcriptomics, and proteomics. Direct quantitative estimations of metabolite expressions in pee, serum, plasma, and tissue are crucial for the investigation of organic procedures in typical and illness states. Subsequent to the quantity of metabolites in a natural example is extensive partition science assumes an imperative part in metabolomic research. Atomic attractive reverberation (NMR) spectroscopy is especially capable for focused investigation since it is quantitative, reproducible, and suitable for complex examples, for example, blood, pee, or tissue removes with practically zero preparing. Thermo Fisher, AB SCIEX, and Bruker likewise offer instruments for imaging MS, additionally called MALDI imaging. To meet difficulties of searchability and information reconciliation, the metabolomics group has a few activities to build up information vaults. Cases are Metabolights in the United Kingdom, bolstered by the European COSMOS (COordination of Standards in MetabOlomicS) consortium that is creating metabolomics information norms, and Metabolomics Workbench, which means to be the database for NIH-subsidized metabolomics ventures. Thermo Fisher teams up with Fiehn on mzcloud.org, a free community database that includes actual and virtual MS spectra with unknown compounds to be annotated as they are identified.

Relevant Metabolomics Conferences Biochemistry Conferences

Track 12 : Analytical Platforms in Metabolomics

In metabolomics, real endeavors are put resources into the advancement of suitable scientific methodologies. Metabolomics, the most youngest field in the 'omics family, is growing rapidly. Developing directly behind genomics, transcriptomics, and proteomics, metabolomics is the extensive examination of little particle metabolites. Subsequent to most metabolites are produced by enzymatic proteins that outcome from quality expression, and metabolites give creatures their biochemical attributes, the metabolome links genotype with phenotype. Metabolomics is as yet growing, however, as merchants adjust division and discovery instruments to meet its difficulties and the examination group deciphers and incorporates the mind boggling information they are gaining. The late quick advancement of a scope of investigative stages, including GC, HPLC, UPLC, CE coupled to MS and NMR spectroscopy, could empower partition, identification, portrayal and evaluation of such metabolites and related metabolic pathways. Proceeded with improvement of these diagnostic stages will quicken far reaching use and coordination of metabolomics into frameworks science. NIH Awards $1.6M to Fund microRNA Biomarker Research in Cancer, Alzheimer's Disease . The Bill and Melinda Gates Foundation today declared $7.7 million in financing for 10 new grants to identify biomarkers for diagnosing tuberculosis (TB) in low-resource settings.

Relevant Metabolomics Conferences Biochemistry Conferences

Track 13 : Data Analysis & Systems Biology

Systems biology is a field within biology aimed at understanding biological processes at the systems level and emerging from dynamic interactions of individual components operating at multiple spatiotemporal scales. Systems biology considers organic Systems by efficiently bothering them (organically, hereditarily, or artificially); observing the quality, protein, and educational pathway reactions; incorporating these information; eventually, planning numerical models that portray the structure of the framework and anticipate its reaction to individual irritations. Integrated “omics” approaches have made energizing open doors for Systems science and other organic examines. Decreases in the expense of producing genomic information have made DNA sequencing, RNA-seq, and high-throughput screening an undeniably imperative piece of biomedical exploration. The National Institute of General Medicine Sciences (NIGMS), an organization of the National Institutes of Health (NIH) supporting fundamental research and research preparing, declared not long ago that it would build up two new divisions — including one concentrated on biomedical innovation, bioinformatics, and computational biology  – – as part of a reorganization that includes the dissolution of the NIH National Center for Research Resources (NCRR) which has had a history of supporting scientific computing.

Relevant Metabolomics Conferences Biochemistry Conferences

Track 14 : Enhancing Analytical Approaches

The rapidly growing area of "metabolomics," in which an extensive number of metabolites from body liquids, cells or tissue are identified quantitatively, in a solitary step, guarantees colossal potential for various orders including early infection conclusion, treatment checking, systems biology,drug discovery and nutritional science. In light of its capacity to distinguish countless in place organic specimens reproducibly and quantitatively, nuclear magnetic resonance (NMR) spectroscopy  has risen as a standout amongst the most intense diagnostic systems in metabolomics. Metabolon, Aglient Technologies, Thermo Scientific, Chenomx and Human Metabolome Technologies, Biocrates Life Sciences, and Metanomics are the main leaders in the metabolomics space. They are dynamic in numerous parts of this business sector: diagnostics item improvement, profiling administrations, scholarly joint efforts, and even acquisitions. Through the NIH Common Fund's Increasing Metabolomics Research Capacity program External Web Site Policy, the NIH has conferred more than $65 million to quicken the field of metabolomics throughout the following five years. The objective of this financing project is to propel a few center regions, including thorough metabolomics asset centers, metabolomics innovation improvement, metabolomics reference gauges combination, and preparing and instructive exercises in metabolomics.

Relevant Metabolomics Conferences Biochemistry Conferences

Track 15 : Case Reports 

Case reports are a vital direct wellspring of confirmation in pharmaceutical and a device regularly utilized as a part of practice to trade data and create a more extended quest for proof. A decent case report will be clear about the significance of the perception being accounted for. A good case report will be clear about the importance of the observation being reported. In addition to the “evidence of what happened”, single or multiple cases are an important basis for further and more advanced research on diagnosis, treatment adequacy, reasons and results of ailment. Case reports might be first to give signs in distinguishing another ailment or unfriendly wellbeing impact from a presentation. Case reports must be authentic, understandable, educational and clinically interesting to an international audience of surgeons, trainees and researchers in all surgical subspecialties, as well as clinicians in related fields.

About Conference

ConferenceSeries Ltd 11th International Conference and Exhibition on Metabolomics & Systems Biology during May 17-19, 2018  Tokyo, Japan. The attending delegates include Editorial Board Members of related OMICS Group Journals. This is a fabulous open door for the representatives from Universities and Institutes to communicate with the world class Scientists.

Metabolomics Congress 2018 Conference will be an investigation of New research Innovation of Metabolomics and spread the most recent advancements and patterns in Metabolomics displaying, Proteomics, Systems Biology, Genomics, Precision Medicine, Lipidomics, LC-MS and GC-MS Techniques, Bioinformatics, Plant Metabolomics, Clinical metabolomics, tumor and digestion system, computational science, metabolomics disorder, Nutritional Metabolomics, Therapeutic Metabolomics and more. Metabolomics is of enthusiasm to doctors in light of the fact that it might prompt enhancements in the conclusion and medications of human illnesses. Metabolomics as an order makes utilization of systematic procedures, for example, spectroscopy, chromatography, and multivariable investigation. Metabolomics permits researchers to gauge physiological impacts and to screen for unfavorable responses to tranquilizes.

Market Analysis

Summary:

Metabolomics is an emerging field which combines strategies to identify and quantify cellular metabolites using sophisticated analytical technologies with the application of statistical and multi-variant methods for information extraction and data interpretation. Metabolomics is the study of small metabolites. Metabolomics Conference deals with topics like Bioinformatics, proteomics, systems biology, Analytical Techniques like NMR, GC-MS, LC-MS and CE-MS, Lipidomics, Metabolic Modelling, Metabolic profiling, clinical metabolomics, Translational sciences, Mass spectrometry, Metabolomics Syndrome, HPLC and CE based metabolomics and more.  Metabolomics - the new "omics" - is a dynamic and developing field, joining genomics, transcriptomics and proteomics in empowering an integrative frameworks science methodology to drug discovery and development. In spite of the fact that metabolomics is still at an early evolutionary stage it is conjecture that throughout the following decade the biopharma business will apply this innovation all the more generally in drug development and information.

'The Future of Metabolomics' gives fully fledged understanding into the compelling utilization of metabolomics all through drug discovery, preclinical development and clinical trials. The report also highlights the use of metabolomics in maximizing and sustaining revenues post-marketing and in the development of clinical diagnostics.

Importance & Scope:

Metabolomics is now being extensively used in pharmaceutical and biotechnology industries for biomarker and drug discovery; pharmaceutical and biotechnology industries are expected to grow at a high rate in coming years, which is expected to boost the growth of the market.

The National Institutes of Health said that they are to invest $14.3 million for metabolomics research, potentially investing more than $51.4 million over five years, to accelerate an emerging field of biomedical research known as metabolomics. As per National Centre for Biotechnology Information. Metabolomics has matured over the past 10 years. Over 300 studies have been completed over the past 5 years.

Why Tokyo, Japan  ?

Japan is the second largest Life science market in the world after USA, Occupying about 10% of Market in each of the global drug and Medical devices market. According to Data monitor , the Japanese biotechnology market had a total revenue of $ 43.3 Billion in 2013 . By 2018, the market is expected to grow to $ 53.8 Billion.

The Japanese pharmaceutical market is the world’s second-largest, with 2013 sales estimated at $115 billion. Japan accounts for a little less than 10 percent of the global Pharma market, compared with 38.4 percent for the U.S. and 20.7 percent for Western Europe

The Japanese market is a promising region for metabolomics companies, as a high amount of metabolomics research is being conducted in the country.

 

                                            Global Life science Market Share by Country

Why to attend ???

Meet Your Target Market With recent business reports on Metabolomics making news which manifests the tremendous growth in market value for metabolomics technology till 2019. Since metabolomics interrelated with omics sciences like Genomics, precision Medicine, Proteomics, Lipidomics, Fluxomics and Transcriptomics, it would be a great opportunity for companies dealing with Analytical instruments useful in these fields. Also many upcoming students and researchers can benefit themselves by participating world class International workshops, symposia during the conference which will be conducted by experts in the respective fields.

Major Metabolomics Related Associations around the Globe :

Metabolomics Society
American association for the advancement of science
American association for clinical chemistry  
American association for cancer research
American association of pharmaceutical scientists
Association for Consumer Research (ACR)
American cancer society
Bioinformatics society of India
Nutrigenomics Organization
The British Society for Genetic Medicine
The Genetics Society
Netherlands metabolomics center
The Australian biotechnology association
Human Proteome Organization
Indiana Proteomics Consortium
Proteome Society
European federation of biotechnology
Australasian Proteomics Society
Clinical Genetics Society

Major Metabolomics Related  Research Units in Japan :

RIKEN Center for Sustainable Resource Science
Institute for Advanced Biosciences, Keio University
Human Metabolome Technologies
Osaka University
University of Tokyo
Kyoto University
University of Tsukuba
Nagoya University
Hokkaido University
University of Tsukuba

Target Audience: 

Directors/Managers & Business Delegates,  Director of Laboratories, Universities, Industries, Investigators, Post Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies.  

Rise in the number of clinical trials, toxicological studies, and health awareness for nutritional products, rapid growth of metabolomics data analysis software and solutions, and use of metabolomics as diagnostics tool for biomarker screening of diseases is expected to propel the growth of this market. 

Glance at Market of Metabolomics:

The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibits the growth of the metabolomics market to a certain extent. Metabolomics science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the metabolomics market.

In 2013, North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.

The global metabolomics market was valued at $565 million in 2014 and is expected to grow at a CAGR of 30% from 2014 to 2019. 

Statistics which shows growth in importance of Metabolomics :

Metabolomics Market Worth $2,100 Million by 2019 - New Report by  Markets and Markets.

Statistics of Industries Associated with Metabolomics :

North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.

The major players in the metabolomics market include Thermo Fisher Scientific (U.S.), Metabolon, Inc. (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.), Agilent Technologies (U.S.), and Bruker Corporation (U.S.). 

Fund Allotment towards Metabolomics Research :

The National Institutes of Health has provided tens of millions of dollars in new funding to support three new Comprehensive Metabolomics Centers at Mayo Clinic, the University of Kentucky, and the University of Florida. 

These three centers will receive an estimated $9 million to $10 million each over the next five years to create resources and initiate research programs that will ramp up the national metabolomics science capabilities.

NIH provided $14.3 million to fund the launch of three other metabolomics resource centers at the University of Michigan, the Research Triangle Institute, and the University of California, Davis.

  • Michigan Regional Comprehensive Metabolomics Resource Core (MRC2) 
  • NIH    West Coast Metabolomics Center at UC Davis
  • Southeast Center for Integrated Metabolomics (SECIM) 
  • Metabolomics Core at Mayo Clinic 
  • Research Center for Stable Isotope Resolved Metabolomics

Funding to UC San Diego for this project is $6 million over five years, part of a total investment by the NIH of $51.4 for the metabolomics project. The awards are supported by the NIH Common Fund.

Metabolomic Diagnostics is engaged in a study called IMPROvED, which has received  €6m in European FP7 funding. 

Mayo Clinic is one of six new federally-funded Comprehensive Metabolomics centres to support medical research on metabolomics — the study, at the cellular level, of how molecules are metabolized in the body. The award from the National Institutes of Health (NIH) is for $8.8 million over five years.  

Past Conference Report

Metabolomics Congress 2017

The 8th International Conference and Exhibition on Metabolomics & Systems Biology, Metabolomics Congress 2017 was held in Singapore, during May 08 - 10, 2017.

Metabolomics Congress 2017 has welcomed the new era of Metabolomics; a futuristic arena for treatment of diseases, clasping a promising tomorrow. The highly exalted conference hosted by Conference Series LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 20 countries around the world. The conference has tried grounding every aspect related to Metabolomics and Cancer, covering all the possible research areas and crux.  

The conference aimed a parallel rail with theme “Rise of New Era in Metabolomics Research”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Metabolomics and Cancer Research, Analytical Techniques in Metabolomics, Applications of Separation Sciences in Metabolomics, Frontiers of Metabolomics Research, Systems biology and Computational Biology, Bioinformatics and Advancements, Clinical Metabolomics and Lipidomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Metabolomics with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

We are thankful to all our speakers for encouraging and supporting us to conduct the conference and catapulting the same to pinnacle of success.

The Organizing Committee would like to thank the moderators Dr. Paul M. Yen, Duke-NUS Medical School, Singapore and Dr. Scott J. Tebbutt, University of British Columbia & PROOF Centre of Excellence, Canada for their contributions which resulted in smooth functioning of the conference.

A series of invited lectures by Honorable guests and members of the Keynote Forum marked the commencement of the event. Prominent scientists like Kenneth K. Wu from CMU, NHRI and NTHU, Taiwan; Walter Wahli from Nanyang Technological University, Singapore; Philipp Kaldis from National University of Singapore, Singapore; Scott J. Tebbutt from University of British Columbia & PROOF Centre of Excellence, Canada; Takeshi Kimura from Ajinomoto Co., Inc., Japan; Sean Pin Ng from Singapore Phenome Center, Singapore; Paul M. Yen from Duke-NUS Medical School, Singapore; Maximilian Zucker from numares HEALTH AG, Germany; Jaleel k Ahmed from Babylon University, Iraq; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series LLC is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artefact.

Conference Series LLC offers its heartfelt appreciation to our sponsor “Bruker, Germany”. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

The supporting Sponsor who continuously shows confidence in our conferences was Bruker.

The best poster presentations were awarded by Dr. Björn Riefke Bayer Pharma AG, Germany to:

Fatima AL-Khelaifi, Anti-Doping Lab, Qatar

Conference Series LLC, on behalf of the conference, congratulates the Best poster awardees for their outstanding performance in the field of Metabolomics and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

Conference Series LLC 8th International Conference and Exhibition on Metabolomics would not have reached the pinnacle if not with the support of international, multi-professional steering committee and coordination of the Journal of Metabolomics: Open Access, Journal of Computer Science and Systems Biology; hence, we express our deep sense of gratitude.

After the successful completion of six consecutive conferences we are glad to announce our next upcoming conferences which is going to be held in Japan,

 “11th International Conference and Exhibition on Metabolomics and Systems Biology” which is going to be held during May 14-16, 2017 in Tokyo, Japan.

Mark your calendars; we are hoping to see you soon!

Let us meet again @ Metabolomics Congress 2018


Past Reports  Proceedings  Gallery  

Metabolomics Congress 2016

Past Reports  Proceedings  Gallery  

Metabolomics-2015

Past Reports  Proceedings  Gallery  

Metabolomics-2014

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date May 17-19, 2018

Speaker Opportunity

Supported By

Journal of Metabolomics:Open Access Journal of Computer Science & Systems Biology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

What People Say....

Thank you as well, and you are welcome! It was a good experience, and I was appreciative of the opportunity to meet and talk with all the conference participants.

Speaker

Jon Rask, Research Scientist, NASA, USA

I enjoyed the conference very much. Cutting-edge and wide range of disciplines, but with a small enough group size to be conducive to excellent discussions and networking.

Speaker

Scott J. Tebbutt, Chief Scientific Officer, PROOF Centre of Excellence, Canada

It is an exciting and wonderful experience during the 3-days meeting, which gives us the opportunity to get to know so many friends and inspire new ideas in our research. Also, the meeting organization is perfect and considerate. We very appreciate all the works you have done for us. I also hope to meet these friends and new friends in the next meeting.

Speaker

Houkai Li, Professor, Shanghai University of Traditional Chinese Medicine, China

Metabolomics-2015 was an enriching meeting that covered multiple topics of interest in the metabolism field. I was pleased to have the opportunity to learn about the development of new techniques to study the abundance and flux of metabolites. Moreover, new platforms to analyze data were presented at the meeting, a key aspect for any research project. Additionally, the meeting provided an excellent opportunity for networking. Overall, I am grateful for my experience and the opportunity to present my project at the meeting.

Speaker

Inmaculada Martinez-Reyes, Scientific Postdoctoral Researcher, Northwestern University, USA

It was my great honor to be a Keynote Speaker for Metabolomics-2015 and to know new colleagues working in the field of metabolomics worldwide. I found that I learned quite a lot from this conference. Thank you very much for organizing this wonderful meeting!

Speaker

Jian Z Hu, Principal investigator, Pacific Northwest National Laboratory, USA

The meeting was well organized from a practical and administrative aspect but the combination of a small meeting with few attendees and diverse aspects of metabolomics did make the conference a bit thin in returning scientific value to my investment in time and money to the meeting. My proposal would be to select fewer main topics.

Speaker

Lars Lofgren, Associate principal scientist, AstraZeneca R&D, Sweden

Congratulate you and your whole team on the grand success of the Conference held in Philadelphia, USA. It was well planned and organized. Since all members of the managing committee were very friendly and sincere we felt homely at all moments. Moreover, my especial thanks are due to you and your team for the kind cooperation, hospitality and management. I look forward and wish you the best for the next meeting to be held in 2016. Once again, I thank you and all the crew members associated with the 4th International Conference and Exhibition on Metabolomics & Systems Biology. With my sincere regards and best wishes, to you and your team.

Speaker

Abdelmegid I. Fahmi, Professor, Menoufia University, Egypt